⌕
Boston Scientific · BSX · NYSE
Tenet 60 · Solid
Compare
$43.03−1.51%At closeTenet 60 · Solid
$43.03−0.66 (−1.51%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
$42.91−0.12 (−0.28%)
After hours: Nov 17, 2026, 7:58 PM ET

Boston Scientific (BSX) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is BSX's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● GlobeNewsWireNov 17, 2026 · 17:07 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX).   Such investors are advised t…

BSX −1.5% todayRead at source ↗
● Defense WorldNov 17, 2026 · 08:49 ETEARNINGS EXPECTED BY FEB 3
Boston Scientific Corporation $BSX Position Reduced by AlTi Global Inc.

AlTi Global Inc. decreased its position in Boston Scientific Corporation (NYSE: BSX) by 76.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,109 shares of …

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchNov 16, 2026 · 11:11 ETEARNINGS EXPECTED BY FEB 3
Should You Book Profits or Hold BSX Stock Post-Q3 Earnings?

Boston Scientific BSX saw modest sales growth in the third quarter, with revenues climbing 1.5% year over year to $5.14 billion, though its adjusted earnings per share (“EPS”) dipped 2.7% to 73 cents year over year. Prim…

BSX −1.5% todayRead at source ↗
● Defense WorldNov 15, 2026 · 09:49 ETEARNINGS EXPECTED BY FEB 3
108,682 Boston Scientific Corporation $BSX Shares Bought by Aberdeen Group plc

Aberdeen Group plc increased its position in shares of Boston Scientific Corporation (NYSE: BSX) by 3.5% during a recent quarter, according to its most recent filing with the Securities and Exchange Commission. The insti…

BSX −1.5% todayRead at source ↗
● Defense WorldNov 14, 2026 · 04:41 ET
Boston Scientific Targets Long-Term Growth as Key Businesses Face Pressure Through 2027

Boston Scientific (NYSE: BSX) executives said they expect durable growth across the company's interventional portfolio, while acknowledging that its pulsed field ablation and WATCHMAN businesses face competitive challeng…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchNov 13, 2026 · 07:21 ETEARNINGS EXPECTED BY FEB 3
Bear of the Day: Boston Scientific (BSX)

I last wrote about Boston Scientific ( BSX ) as the Bear of the Day in early August after their Q2 report and management's lowered guidance propelled analysts to notch down their EPS estimates for this year and next, cau…

BSX −1.5% todayRead at source ↗
● Defense WorldNov 13, 2026 · 03:55 ETEARNINGS EXPECTED BY FEB 3
72,575 Boston Scientific Corporation $BSX Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC cut its position in shares of Boston Scientific Corporation (NYSE: BSX) by 11.4% in a recent quarter, according to its most recent disclosure with the Securities and Exchange Com…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchNov 12, 2026 · 13:25 ET
Boston Scientific Bets on WATCHMAN Growth Despite Market Slowdown

BSX bets on WATCHMAN growth through clinical trials and physician outreach, even as slowing demand and rising competition cloud its outlook.…

BSX −1.5% todayRead at source ↗
● PRNewsWireNov 12, 2026 · 10:35 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).   Such investors are advised to co…

BSX −1.5% todayRead at source ↗
● Defense WorldNov 12, 2026 · 03:49 ETEARNINGS EXPECTED BY FEB 3
AMG National Trust Bank Acquires 34,303 Shares of Boston Scientific Corporation $BSX

AMG National Trust Bank bought a new stake in shares of Boston Scientific Corporation (NYSE: BSX) during a recent quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institut…

BSX −1.5% todayRead at source ↗
● Seeking AlphaNov 11, 2026 · 11:39 ET
Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript

Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchNov 10, 2026 · 10:31 ET
Wall Street Analysts Look Bullish on Boston Scientific (BSX): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) ana…

BSX −1.5% todayRead at source ↗
● Defense WorldNov 9, 2026 · 04:01 ETEARNINGS EXPECTED BY FEB 3
Boston Scientific Corporation $BSX Stock Bought by Ethic Inc.

Ethic Inc. boosted its position in Boston Scientific Corporation (NYSE: BSX) by 11.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institut…

BSX −1.5% todayRead at source ↗
● Business WireNov 5, 2026 · 16:00 ET
BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation's Directors and Officers for Breach of Fiduciary Duties – BSX

NEW YORK--(BUSINESS WIRE)---- $BSX #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Bo…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchNov 5, 2026 · 10:01 ET
Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock

Boston Scientific (BSX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 10:56 ETEARNINGS EXPECTED BY FEB 3
BSX Q3 Results Reset Growth Expectations as 2027 Outlook Stays Weak

Boston Scientific's cyber disruption cuts Q3 growth and earnings, forcing lower 2026 guidance as management sees 2027 as the cycle's trough.…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchNov 3, 2026 · 10:26 ETEARNINGS EXPECTED BY FEB 3
Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth?

Boston Scientific's steep valuation discount faces a major test as earnings estimates weaken, core franchises lose momentum and key growth catalysts shift to 2028.…

BSX −1.5% todayRead at source ↗
● Business WireNov 2, 2026 · 17:54 ET
Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blackstone Life Sciences (“BXLS”) today announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the development of the VITALYST™ Temporary Percu…

BSX −1.5% todayRead at source ↗
● PRNewsWireNov 2, 2026 · 14:02 ET
SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints

Both post-implant monotherapies in the trial achieved non-inferiority compared to dual anti-platelet therapy (DAPT) supporting the potential to simplify post-procedure drug regimens MARLBOROUGH, Mass. and SAN DIEGO, Nov.…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchOct 30, 2026 · 16:01 ETEARNINGS EXPECTED BY FEB 3
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?

Intuitive Surgical's surging robotic surgery demand and stronger earnings momentum make it a better buy than Boston Scientific despite its valuation premium.…

BSX −1.5% todayRead at source ↗
● 24/7 Wall StreetOct 30, 2026 · 08:14 ET
Buy, Sell, or Hold? Today's Top Upgrades and Downgrades: Boston Scientific, DoorDash, GE Vernova, Honeywell Aerospace, Incyte.

Pre-Market Stock Futures: Futures are trading lower this Friday, with the Nasdaq down almost 2.…

BSX −1.5% todayRead at source ↗
● Zacks Investment ResearchOct 30, 2026 · 06:51 ET
New Strong Sell Stocks for October 30th

BSX, NBHC and NMRK have been added to the Zacks Rank #5 (Strong Sell) List on October 30th, 2026.…

BSX −1.5% todayRead at source ↗
● PRNewsWireOct 28, 2026 · 06:30 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 3
Boston Scientific announces results for third quarter 2026

MARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational1 and orga…

BSX −1.5% todayRead at source ↗
● PRNewsWireOct 26, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Boston Scientific to participate in Stifel's 2026 Healthcare Conference

MARLBOROUGH, Mass., Oct. 26, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on Wednesday, November 11, 2026.…

BSX −1.5% todayRead at source ↗
● Business WireOct 22, 2026 · 08:30 ET
BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT:  Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation's Directors and Officers for Breach of Fiduciary Duties – BSX

NEW YORK--(BUSINESS WIRE)---- $BSX #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Bo…

BSX −1.5% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 3. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA31−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just BSX · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.